O'Connell JR

References (3)

Title : Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response - Backman_2017_Pharmacogenet.Genomics_27_159
Author(s) : Backman JD , O'Connell JR , Tanner K , Peer CJ , Figg WD , Spencer SD , Mitchell BD , Shuldiner AR , Yerges-Armstrong LM , Horenstein RB , Lewis JP
Ref : Pharmacogenet Genomics , 27 :159 , 2017
PubMedID: 28207573

Title : Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes - Albert_2014_N.Engl.J.Med_370_2307
Author(s) : Albert JS , Yerges-Armstrong LM , Horenstein RB , Pollin TI , Sreenivasan UT , Chai S , Blaner WS , Snitker S , O'Connell JR , Gong DW , Breyer RJ, 3rd , Ryan AS , McLenithan JC , Shuldiner AR , Sztalryd C , Damcott CM
Ref : N Engl J Med , 370 :2307 , 2014
PubMedID: 24848981
Gene_locus related to this paper: human-LIPE

Title : The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response - Lewis_2013_Pharmacogenet.Genomics_23_1
Author(s) : Lewis JP , Horenstein RB , Ryan K , O'Connell JR , Gibson Q , Mitchell BD , Tanner K , Chai S , Bliden KP , Tantry US , Peer CJ , Figg WD , Spencer SD , Pacanowski MA , Gurbel PA , Shuldiner AR
Ref : Pharmacogenet Genomics , 23 :1 , 2013
PubMedID: 23111421
Gene_locus related to this paper: human-CES1